Helicobacter pylori update: Gastric cancer, reliable therapy, and possible benefits

Gastroenterology

Volumn 148, Issue 4, 2015, Pages 719-731.e3

  Graham, David Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteria; Barrett's Esophagus; Esophageal Adenocarcinoma; Prevention; Stomach Cancer

Indexed keywords

ANTIBIOTIC AGENT; ANTACID AGENT; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ASTHMA; CARCINOGENESIS; CLINICAL RESEARCH; ERADICATION THERAPY; ESOPHAGUS DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; TREATMENT FAILURE; ADENOCARCINOMA; COMPLICATION; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; MICROBIOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ANTACIDS; ANTI-BACTERIAL AGENTS; ASTHMA; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OBESITY; PROTON PUMP INHIBITORS; STOMACH NEOPLASMS;

EID: 84925358100     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.01.040     Document Type: Review

References (112)

1. N.R. Salama, M.L. Hartung, and A. Muller Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori Nat Rev Microbiol 11 2013 385 399
2. Y. Yamaoka, and D.Y. Graham Helicobacter pylori virulence and cancer pathogenesis Future Oncol 10 2014 1487 1500
3. K. Hanada, and D.Y. Graham Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma Expert Rev Anticancer Ther 14 2014 947 954
4. D.M. Hardbower, R.M. Peek Jr., and K.T. Wilson At the bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer J Leukoc Biol 96 2014 201 212
5. D.Y. Graham History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer World J Gastroenterol 20 2014 5191 5204
6. A. Shiotani, P. Cen, and D.Y. Graham Eradication of gastric cancer is now both possible and practical Semin Cancer Biol 23 2013 492 501
7. Y. Hayakawa, J.G. Fox, and T. Gonda Mouse models of gastric cancer Cancers (Basel) 5 2013 92 130
8. S. Yu, M. Yang, and K.T. Nam Mouse models of gastric carcinogenesis J Gastric Cancer 14 2014 67 86
9. T. Tsukamoto, T. Toyoda, and T. Mizoshita Helicobacter pylori infection and gastric carcinogenesis in rodent models Semin Immunopathol 35 2013 177 190
10. D.E. Freedberg, J.A. Abrams, and T.C. Wang Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori? J Natl Cancer Inst 106 2014
11. M.B. Bracken Risk, chance, and causation 2013 Yale University Press New Haven
12. M. Asaka, M. Kato, and N. Sakamoto Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan J Gastroenterol 49 2014 1 8
13. M. Asaka A new approach for elimination of gastric cancer deaths in Japan Int J Cancer 132 2013 1272 1276
14. IARC Helicobacter pylori working group Helicobacter pylori eradication as a strategy for preventing gastric cancer. Vol 8 2014 International Agency for Research on Cancer Leon
15. Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015. In press.
16. S.J. Czinn, and T. Blanchard Vaccinating against Helicobacter pylori infection Nat Rev Gastroenterol Hepatol 8 2011 133 140
17. I. Lansdorp-Vogelaar, and L. Sharp Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention Best Pract Res Clin Gastroenterol 27 2013 933 947
18. M. Areia, M. Dinis-Ribeiro, and G.F. Rocha Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions Helicobacter 19 2014 425 436
19. M. Rugge, P. Correa, and M.F. Di OLGA staging for gastritis: a tutorial Dig Liver Dis 40 2008 650 658
20. L.G. Capelle, A.C. de Vries, and J. Haringsma The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis Gastrointest Endosc 71 2010 1150 1158
21. M. Kaise, J. Miwa, and A. Fujimoto Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker Gastric Cancer 16 2013 329 337
22. T. Kawai, K. Miki, and M. Ichinose Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan Inflammopharmacology 15 2007 31 35
23. K. Fukase, M. Kato, and S. Kikuchi Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
24. S.B. Yoon, J.M. Park, and C.H. Lim Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis Helicobacter 19 2014 243 248
25. S. Matsueda, and D.Y. Graham Immunotherapy in gastric cancer World J Gastroenterol 20 2014 1657 1666
26. C. Wang, A. Weber, and D.Y. Graham Age-, period- and cohort effects on gastric cancer mortality Dig Dis Sci 60 2015 514 523
27. K. Hanada, T. Uchida, and Y. Tsukamoto Helicobacter pylori-infection introduces DNA double-strand breaks in host cells Infect Immun 82 2014 4182 4189
28. W.J. Chang, Y. Du, and X. Zhao Inflammation-related factors predicting prognosis of gastric cancer World J Gastroenterol 20 2014 4586 4596
29. D.Y. Graham, S. Matsueda, and A. Shiotani Changing the natural history of metachronous gastric cancer after H pylori eradication Japanese J Helicobacter Res 16 2015 52 60
30. A.O. Chan, S.K. Lam, and B.C. Wong Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer Gut 52 2003 502 506
31. S.G. Conticello The AID/APOBEC family of nucleic acid mutators Genome Biol 9 2008 229
32. Y. Matsumoto, H. Marusawa, and K. Kinoshita Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium Nat Med 13 2007 470 476
33. T. Shimizu, H. Marusawa, and Y. Endo Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis Cancer Sci 103 2012 1201 1206
34. F. Perri, R. Cotugno, and A. Piepoli Aberrant DNA methylation in non-neoplastic gastric mucosa of H pylori infected patients and effect of eradication Am J Gastroenterol 102 2007 1361 1371
35. A.O. Chan, J.Z. Peng, and S.K. Lam Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation Gut 55 2006 463 468
36. W.K. Leung, E.P. Man, and J. Yu Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach Clin Cancer Res 12 2006 3216 3221
37. H.N. Lee, H.K. Na, and Y.J. Surh Resolution of inflammation as a novel chemopreventive strategy Semin Immunopathol 35 2013 151 161
38. S. Ardeman, and I. Chanarin Steroids and addisonian pernicious anemia N Engl J Med 273 1965 1352 1355
39. G.H. Jeffries, J.E. Todd, and M.H. Sleisenger The effect of prednisolone on gastric mucosal histology, gastric secretion, and vitamin B 12 absorption in patients with pernicious anemia J Clin Invest 45 1966 803 812
40. M. Siurala, P. Peltola, and K. Varis The effect of long-term treatment with prednisone upon the state of the human gastric mucosa Scand J Gastroenterol 3 1968 407 412
41. R.T. Baggett, and J.D. Welsh Observations on the effects of glucocorticoid administration in pernicious anemia Am J Dig Dis 15 1970 871 881
42. I.M. Toller, M. Altmeyer, and E. Kohler Inhibition of ADP ribosylation prevents and cures Helicobacter-induced gastric preneoplasia Cancer Res 70 2010 5912 5922
43. I.M. Toller, I. Hitzler, and A. Sayi Prostaglandin E2 prevents Helicobacter-induced gastric preneoplasia and facilitates persistent infection in a mouse model Gastroenterology 138 2010 1455 1467
44. J.R. Goldenring Gastric intestinal metaplasia and tamoxifen: can we reverse the inevitable? Dig Dis Sci 59 2014 1078 1079
45. P. Mesquita, A. Raquel, and L. Nuno Metaplasia-a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia Crit Rev Oncog 12 2006 3 26
46. K. Wang, S.T. Yuen, and J. Xu Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer Nat Genet 46 2014 573 582
47. M. Razzak Genetics: new molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas Nat Rev Clin Oncol 11 2014 499
48. J.P. Gisbert, X. Calvet, and A. O'connor Sequential therapy for Helicobacter pylori eradication: a critical review J Clin Gastroenterol 44 2010 313 325
49. Y. Li, X. Huang, and L. Yao Advantages of moxifloxacin and levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis Wien Klin Wochenschr 122 2010 413 422
50. H. Ogilvie Whither medicine? Lancet 2 1952 820 824
51. D.Y. Graham Helicobacter pylori eradication therapy research: ethical issues and description of results Clin Gastroenterol Hepatol 8 2010 1032 1036
52. E. Rimbara, L.A. Fischbach, and D.Y. Graham Optimal therapy for Helicobacter pylori infections Nat Rev Gastroenterol Hepatol 8 2011 79 88
53. D.Y. Graham, Y.C. Lee, and M.S. Wu Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence Clin Gastroenterol Hepatol 12 2014 177 186
54. J.Y. Wu, J.M. Liou, and D.Y. Graham Evidence-based recommendations for successful Helicobacter pylori treatment Expert Rev Gastroenterol Hepatol 8 2014 21 28
55. X. Calvet, J. Sanchez-Delgado, and A. Montserrat Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal Clin Infect Dis 48 2009 1385 1391
56. Y.H. Kwon, N. Kim, and J.Y. Lee The diagnostic validity of citric acid-free, high dose 13C-urea breath test after Helicobacter pylori eradication in Korea Helicobacter 2015 Epub ahead of print
57. C. Kato, T. Sugiyama, and K. Sato Appropriate cut-off value of 13C-urea breath test after eradication of Helicobacter pylori infection in Japan J Gastroenterol Hepatol 18 2003 1379 1383
58. D.Y. Graham, H.M. Malaty, and R.A. Cole Simplified 13C-urea breath test for detection of Helicobacter pylori infection Am J Gastroenterol 96 2001 1741 1745
59. M.B. Bracken Harm Bracken MB. Risk, chance, and causation 2013 Yale University Press New Haven 108 109
60. R. Sessa, M.D. Pietro, and S. Filardo Infectious burden and atherosclerosis: a clinical issue World J Clin Cases 2 2014 240 249
61. G.S. Thomas, L.S. Wann, and A.H. Allam Why did ancient people have atherosclerosis? Global Heart 9 2014 229 237
62. R.C. Thompson, A.H. Allam, and A. Zink Computed tomographic evidence of atherosclerosis in the mummified remains of humans from around the world Global Heart 9 2014 187 196
63. E.G. Nabel, and E. Braunwald A tale of coronary artery disease and myocardial infarction N Engl J Med 366 2012 54 63
64. D. Falush, T. Wirth, and B. Linz Traces of human migrations in Helicobacter pylori populations Science 299 2003 1582 1585
65. F. Franceschi, A. Tortora, and G. Gasbarrini Helicobacter pylori and extragastric diseases Helicobacter 19 Suppl 1 2014 52 58
66. D.J. Lamb, W. El Sankary, and G.A. Ferns Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation Atherosclerosis 167 2003 177 185
67. G.M. Buzas Metabolic consequences of infection and eradication World J Gastroenterol 20 2014 5226 5234
68. Editorial: cardiovascular disease and peptic ulcer Br Med J 3 1974 760 761
69. W.S. Hughes An hypothesis: the dramatic decline in heart attacks in the United States is temporally related to the decline in duodenal ulcer and Helicobacter pylori infection Helicobacter 19 2014 239 241
70. W.F. Enos, R.H. Holmes, and J. Beyer Coronary disease among United States soldiers killed in action in Korea JAMA 152 1953 1090 1093
71. J.J. McNamara, M.A. Molot, and J.F. Stremple Coronary artery disease in combat casualties in Vietnam JAMA 216 1971 1185 1187
72. B.J. Webber, P.G. Seguin, and D.G. Burnett Prevalence of and risk factors for autopsy-determined atherosclerosis among US service members, 2001-2011 JAMA 308 2012 2577 2583
73. D.Y. Graham, H.M. Malaty, and D.G. Evans Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status Gastroenterology 100 1991 1495 1501
74. Parsonnet J. Are there benefits of Helicobacter pylori infection? In: IARC Helicobacter pylori working group; Helicobacter pylori eradication as a strategy for preventing gastric cancer. Vol 8. Leon: 2014:72-78.
75. P. Malfertheiner, F. Megraud, and C.A. O'Morain Management of Helicobacter pylori infection-the Maastricht IV/Florence consensus report Gut 61 2012 646 664
76. D.Y. Graham The changing epidemiology of GERD: geography and Helicobacter pylori Am J Gastroenterol 98 2003 1462 1470
77. Y. Liu, J. Akiyama, and D.Y. Graham Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease Minerva Gastroenterol Dietol 52 2006 235 248
78. M.P. Dore, and D.Y. Graham Helicobacter pylori and gastroesophageal reflux disease 1st ed. M.F. Vela, J.E. Richter, J.D. Pandolfino, Practical manual of gastroesophageal reflux disease 2013 John Wiley & Sons, Ltd Hoboken 267 285
79. SEER cancer statistics review (CSR) 1975-2011. 2014.
80. Y. Chen, and M.J. Blaser Helicobacter pylori colonization is inversely associated with childhood asthma J Infect Dis 198 2008 553 560
81. M.R. Sears Trends in the prevalence of asthma Chest 145 2014 219 225
82. C.R. Simpson, and A. Sheikh Trends in the epidemiology of asthma in England: a national study of 333,294 patients J R Soc Med 103 2010 98 106
83. C.P. van Schayck, and H.A. Smit The prevalence of asthma in children: a reversing trend Eur Respir J 26 2005 647 650
84. A.L. Ponsonby, N. Glasgow, and A. Pezic A temporal decline in asthma but not eczema prevalence from 2000 to 2005 at school entry in the Australian Capital Territory with further consideration of country of birth Int J Epidemiol 37 2008 559 569
85. M. Oertli, M. Sundquist, and I. Hitzler DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection J Clin Invest 122 2012 1082 1096
86. M. Oertli, M. Noben, and D.B. Engler Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance Proc Natl Acad Sci U S A 110 2013 3047 3052
87. A. Kandulski, T. Wex, and D. Kuester Naturally occurring regulatory T cells (CD4+, CD25 high, FOXP3+) in the antrum and cardia are associated with higher H pylori colonization and increased gene expression of TGF-beta1 Helicobacter 13 2008 295 303
88. A. Kandulski, P. Malfertheiner, and T. Wex Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer Anticancer Res 30 2010 1093 1103
89. Y.Y. Lee, R.S. Mahendra, and D.Y. Graham Helicobacter pylori infection - a boon or a bane: lessons from studies in a low-prevalence population Helicobacter 18 2013 338 346
90. K.E. Fujimura, T. Demoor, and M. Rauch House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection Proc Natl Acad Sci U S A 111 2014 805 810
91. H. Renz, P. Brandtzaeg, and M. Hornef The impact of perinatal immune development on mucosal homeostasis and chronic inflammation Nat Rev Immunol 12 2012 9 23
92. E.P. Prentice Hunger and history: the influence of hunger on human history 1939 Harper & Brothers New York
93. J. de Castro The geography of hunger 1952 Little, Brown and Company Scranton
94. E.F. Hurtado-Lopez, and R. Macias-Rosales Focus of childhood obesity from pediatrics Rev Med Inst Mex Seguro Soc 52 Suppl 1 2014 S116 S119
95. M. Safdie, M. Cargo, and L. Richard An ecological and theoretical deconstruction of a school-based obesity prevention program in Mexico Int J Behav Nutr Phys Act 11 2014 103
96. A.S. Alvarez-Villasenor, and V. George-Flores Overweight and obesity among children in nurseries Rev Med Inst Mex Seguro Soc 52 2014 606 609
97. M.J. Blaser, and S. Falkow What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7 2009 887 894
98. N. Lender, N.J. Talley, and P. Enck Review article: associations between Helicobacter pylori and obesity-an ecological study Aliment Pharmacol Ther 40 2014 24 31
99. C. Xu, M. Yan, Y. Sun, and J. Joo Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population Helicobacter 19 2014 437 442
100. M. Morris Salt sugar fat: how the food giants hooked us 2013 Random House New York, NY
101. M. Nestle Food politics. How the food industry influences nutrition and health 2002 University of California Press Berkeley
102. M.N. Ismail, S.S. Chee, and H. Nawawi Obesity in Malaysia Obes Rev 3 2002 203 208
103. M.N. Ismail The nutrition and health transition in Malaysia Public Health Nutrition 5 2002 191 195
104. L. Rampal, S. Rampal, and G.L. Khor A national study on the prevalence of obesity among 16,127 Malaysians Asia Pac J Clin Nutr 16 2007 561 566
105. Cancer incidence in five continents. Publication no. 155 2004 IARC Scientific Publications Lyon
106. M.I. Grossman Closing remarks Gastroenterology 74 1978 487 488
107. Y. Chen, S. Segers, and M.J. Blaser Association between Helicobacter pylori and mortality in the NHANES III study Gut 62 2013 1262 1269
108. W.F. Anderson, M.C. Camargo, and J.F. Fraumeni Jr. Age-specific trends in incidence of noncardia gastric cancer in US adults JAMA 303 2010 1723 1728
109. D.Y. Graham, Y.C. Lee, and M.S. Wu Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence Clin Gastroenterol Hepatol 12 2014 177 186
110. J.Y. Wu, J.M. Liou, and D.Y. Graham Evidence-based recommendations for successful Helicobacter pylori treatment Expert Rev Gastroenterol Hepatol 8 2014 21 28
111. C.S. Park, S.M. Lee, and C.H. Park Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance Am J Gastroenterol 109 2014 1595 1602
112. C.O. Salazar, V.M. Cardenas, and R.K. Reddy Greater than 95% success with 14-day bismuth quadruple anti-Helicobacter pylori therapy: a pilot study in US Hispanics Helicobacter 17 2012 382 389